SciSparc Ltd. logo

SciSparc Ltd.

0001611746

SciSparc is a specialty pharmaceutical company developing unique cannabinoid technologies for the treatment of central nervous system disorders. Their pipeline includes drug candidates in clinical trials for Tourette Syndrome, Obstructive Sleep Apnea, Alzheimer’s Disease, Agitation, and Autism Spectrum Disorder. The company focuses on improving the lives of those suffering from central nervous system disorders.

89
Mycket Pålitlig
Förtroendepoäng

Officiellt Register

Momsnummer
000000000
Adress
20 RAUL WALLENBERG STREET, TOWER A, TEL AVIV, L3 6971916
Branschkoder
Retail-Auto Dealers & Gasoline Stations, 5500

AI Kvalitetsanalys

Bransch
Pharmaceutical
SSL/HTTPS
Säker
Professionell E-post
Ja
Kontakt E-post
ir@scisparc.com

Förtroendepoäng Detaljer

Register Verifierat35/35
Kvalitetspoäng54/60
Nyhetsanalys0/5

Snabblänkar

Senast uppdaterad: 1/2/2026

🌟 Liknande Pålitliga Företag

Addex Therapeutics Ltd.

Addex Therapeutics Ltd. logo
81/100 · Mycket Pålitlig

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Their pipeline includes compounds targeting post-stroke recovery, substance use disorder and chronic cough. The company utilizes its expertise in allosteric modulation for drug discovery.

CHEMIN DES MINES 9, USA
Visa profil

SERVIER OUTRE-MER

SERVIER OUTRE-MER logo
85/100 · Mycket Pålitlig

Servier is an independent international pharmaceutical company focused on therapeutic progress for patients. They invest significantly in research and development, particularly in oncology, cardiometabolism, and neuroscience. Servier is known for its long-term vision and commitment to patients' needs.

50 RUE CARNOT 92150 SURESNES, France
Visa profil

AGILERA PHARMA AS

AGILERA PHARMA AS logo
75/100 · Pålitlig

Agilera är ett ledande CDMO som bidrar till teknikutveckling och tillväxt på radioläkemedelsmarknaden. De erbjuder hela värdekedjan för utveckling av nya radioläkemedel, från preklinisk fas till kommersiell produktion och global distribution. Agilera är godkänd som tillverkare för USA, Japan, Europa, Latinamerika och Kina.

Instituttveien 18, Norway
Visa profil